» Articles » PMID: 38606301

Prohibitin Expression in Antigen-Presenting Cells: Implications for Inciting Trigger in CNS IgG4-Related Disease

Abstract

Immunoglobulin G4-related disease (IgG4-RD) is a rare autoimmune disorder with an unknown etiology. Using orthogonal immune profiling and automated sequential multiplexing, we found an enhanced frequency of activated circulating B cells, antigen-presenting myeloid cells in peripheral blood, and a distinct distribution of immune cells within the CNS lesions. Prohibitin-expressing CD138+ plasma B cells and CD11c+ dendritic cells have been found interacting with T cells resulting in irmnune cell activation within the lesion. The data implicate prohibitin as a potential triggering antigen in the pathogenesis of IgG4-RD and shed light on the cellular dynamics and interactions driving IgG4-RD in the central nervous system, emphasizing the need for further studies corroborating these findings.

References
1.
Lucas C, Cordero-Nieves H, Erbe R, McAlees J, Bhatia S, Hodes R . Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes. J Immunol. 2012; 190(2):723-36. PMC: 3538926. DOI: 10.4049/jimmunol.1201646. View

2.
Friedrich M, Kehl N, Engelke N, Kraus J, Lindner K, Munch P . Intrathecal activation of CD8 memory T cells in IgG4-related disease of the brain parenchyma. EMBO Mol Med. 2021; 13(8):e13953. PMC: 8350898. DOI: 10.15252/emmm.202113953. View

3.
Newman A, Liu C, Green M, Gentles A, Feng W, Xu Y . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015; 12(5):453-7. PMC: 4739640. DOI: 10.1038/nmeth.3337. View

4.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T . Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012; 22(1):21-30. DOI: 10.1007/s10165-011-0571-z. View

5.
Winkel M, Lawton C, Sanusi O, Horbinski C, Dahdaleh N, Smith Z . Neuro-surgical considerations for treating IgG4-related disease with rare spinal epidural compression. Surg Neurol Int. 2018; 9:209. PMC: 6213809. DOI: 10.4103/sni.sni_156_18. View